Kersting, David
Jentzen, Walter
Fragoso Costa, Pedro
Sraieb, Miriam
Sandach, Patrick
Umutlu, Lale
Conti, Maurizio
Zarrad, Fadi
Rischpler, Christoph
Fendler, Wolfgang Peter
Herrmann, Ken
Weber, Manuel
Funding for this research was provided by:
Siemens Healthineers
Universitätsklinikum Essen
Article History
Received: 9 March 2021
Accepted: 29 July 2021
First Online: 1 September 2021
Change Date: 16 November 2023
Change Type: Update
Change Details: The original online version of this Article was revised: In the original version of this Article, the author names were incorrectly indexed. The original Article has been corrected.
Competing interests
: Walter Jentzen received research funding from Siemens Healthineers. Lale Umutlu is a Speaker / Advisory Board Member for Bayer Healthcare and Siemens Healthcare and received research grants from Siemens Healthcare, outside of the submitted work. Maurizio Conti is a full-time employee of Siemens Medical Solutions USA, Inc. Christoph Rischpler received research funding from Pfizer, outside of the submitted work. Wolfgang P. Fendler is a consultant for Endocyte and BTG, and he received fees from RadioMedix, Bayer, and Parexel outside of the submitted work. Ken Herrmann reports personal fees from Bayer, personal fees and other from Sofie Biosciences, personal fees from SIRTEX, non-financial support from ABX, personal fees from Adacap, personal fees from Curium, personal fees from Endocyte, grants and personal fees from BTG, personal fees from IPSEN, personal fees from Siemens Healthineers, personal fees from GE Healthcare, personal fees from Amgen, personal fees from Novartis, personal fees from ymabs, outside of the submitted work. David Kersting, Pedro Fragoso Costa, Miriam Sraieb, Patrick Sandach, Fadi Zarrad and Manuel Weber declare no competing interests.